This article is in the news archive.
Congratulations to Professor Alastair Compston on being appointed CBE
Cambridge Neuroscience wish to congratulate Professor Alastair Compston who was recognised in the New Year's honours list.
Professor of Neurology Alastair Compston was appointed CBE ‘for services to multiple sclerosis treatment’. Compston has been involved with research on the mechanisms and treatment of multiple sclerosis since 1976, the last 26 years based in Cambridge. Apart from work identifying many genetic risk variants for susceptibility to the disease, he has introduced Alemtuzumab (Lemtrada) as a highly effective treatment for early relapsing-remitting multiple sclerosis. Since 2013, Alemtuzumab has been licensed throughout the world and is now used increasingly as a first-line therapy in young adults with this potentially disabling condition. Compston, a Fellow of Jesus College, said: “I am delighted to receive this honour but especially pleased that the citation recognises the work of a large research community, in Cambridge and elsewhere, that has transformed the outlook for young people with multiple sclerosis facing an otherwise uncertain future.”
For more on Cambridge Academics recognised over the New Year see here.
Posted on 05/01/2016
Go to the news index page.